CORT news

Latest 3 stories · newest Sep 23, 2026

CORT

Corcept Names Justin Gunn President of Endocrinology Division

Corcept Therapeutics Inc. announced Justin Gunn will succeed retiring President Sean Maduck to lead the Endocrinology division. This leadership transition reflects the company's continued commercial strengthening and focus on its Cushing's syndrome treatment strategy.

Leadership Sep 23, 2026 sentiment +0.20 SEC filing ↗

CORT

Corcept Resubmits NDA for Relacorilant to Treat Cushing's Syndrome

Corcept Therapeutics resubmitted its New Drug Application to the FDA for relacorilant, incorporating additional data analyses requested by the agency, with an expected six-month review timeline. The resubmission is based on positive Phase III trial data showing the drug provides meaningful improveme…

Regulatory Jun 17, 2026 sentiment +0.75 SEC filing ↗

CORT

7 Health Care Stocks With Whale Alerts In Today's Session

Options Jun 9, 2026 sentiment 0.00 Source: benzinga.com ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same CORT feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/CORT/newsSTART FREE